Dr Reddys Q4FY17 Consolidated Net Profit Rises 179% Yoy


Dr Reddy consolidated revenue for the quarter came in at Rs. 3612 crore, registering 4.8% yoy decline. This was mainly driven by 7% yoy decrease in Pharmaceutical services.

EBITDA for the quarter rose by 22.6% yoy to Rs. 591 crore with a corresponding margin expansion of 366 bps. EBITDA margin for the quarter stood at 16.4%. This margin expansion was driven by decrease in cost of raw material and other expenses by 24% yoy and 16.6% yoy respectively.

The PAT for the quarter came in at Rs. 327 crore, yoy increase of 179%.

Looking at the full year numbers, we see that revenue slided by 9% to reach Rs.14196.1 crore while EBITDA fell by 31% to 2472.2 crore. Company reported net profit of Rs.1257.2 crore, down 40% yoy.

The Board of Directors have recommended a final dividend of Rs. 20 per equity share for the face value of Rs. 5 each for FY16-17.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 
Give a Missed Call for Free Trial - 09699997717 
Share on Google Plus

About Suhani Varma

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

0 comments: